Dr. Gail Cassell is currently Vice President, Scientific Affairs and Distinguished Lilly Research Scholar for Infectious Diseases, Eli Lilly and Company, Lilly Research Laboratories, in Indianapolis, Indiana. She is the former Charles H. McCauley Professor and Chairman of the Department of Microbiology at the University of Alabama School of Medicine.
She has previously served as a member of the National Institutes of Health Director's Advisory Committee; member and Chair of the Board of Scientific Councilors of the Center for Infectious Diseases, Centers for Disease Control; member Advisory Board of the Director of the CDC, and is currently a member of the Science Board of the Federal Food and Drug Administration and a member of the Leadership Council of Harvard University’s School of Public Health and the Advisory Board of the Johns Hopkins School of Nursing.
Dr. Cassell has been intimately involved in establishment of science policy and legislation related to biomedical research and public health. She is the chairman of the Public and Scientific Affairs Board of the American Society of Microbiology, has served as an advisor on infectious diseases and indirect costs of research to the White House Office of Science and Technology Policy, and has been an invited participant in numerous Congressional hearings and briefings related to infectious diseases, antimicrobial resistance, and biomedical research. With regards to medical education, Dr. Cassell served two terms on the LCMS, the Accreditation body of the American Medical Association and the American Association for Medical Schools. She has also served on the Microbiology exam construction committees of the Part I National Board of Medical Examiners. She has served on several editorial boards of scientific journals and has authored over 250 articles and book chapters. Dr. Cassell has received national and international awards and an honorary degree for her research in infectious diseases and is a member of the Institute of Medicine (IOM) of the National Academy of Sciences, and a member of the IOM Council 2005-2008. She is a member of the Board of Burroughs Wellcome Fund, Research!America, and the Global Alliance for TB Drug Development.